Gallacher Capital Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-10,004
Closed -$790K 315
2025
Q4
$790K Sell
10,004
-3,734
-27% -$293K 0.31% 84
2025
Q3
$1.1M Buy
13,738
+1,915
+16% +$163K 0.43% 46
2025
Q2
$1.07M Buy
11,823
+986
+9% +$90K 0.5% 38
2025
Q1
$1.02M Buy
10,837
+1,326
+14% +$119K 0.49% 37
2024
Q4
$865K Buy
9,511
+987
+12% +$94.2K 0.43% 44
2024
Q3
$885K Buy
+8,524
New +$869K 0.41% 40
2024
Q2
Sell
-6,481
Closed -$584K 279
2024
Q1
$584K Buy
+6,481
New +$549K 0.3% 56

Other funds holding CL

Gallacher Capital Management's CL Position: Q1 2026 in Review

Gallacher Capital Management sold out of Colgate-Palmolive (CL) in Q1 2026, closing a stake of 10,004 shares — an estimated $790K sold.

Gallacher Capital Management first reported a position in CL in Q1 2024 and held it in 7 quarters. The position peaked at $1.1M in Q3 2025. 1,945 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Gallacher Capital Management reported no remaining Colgate-Palmolive position as of Q1 2026 after selling out during the quarter.
  • Gallacher Capital Management sold 10,004 Colgate-Palmolive shares in Q1 2026, an estimated $790K.
  • Gallacher Capital Management first reported a position in Colgate-Palmolive in Q1 2024 and held it in 7 quarters.
  • Gallacher Capital Management's Colgate-Palmolive position peaked at $1.1M in Q3 2025.
  • 1,945 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Gallacher Capital Management's 13F filing for Q1 2026, filed 6 May 2026.